Fact Sheet for Healthcare Providers: DPP ® COVID-19 IgM/IgG System – Chembio Diagnostic Systems, Inc.

Source: U.S. Food and Drug Administration (FDA). Published: 4/14/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the DPP ® COVID-19 IgM/IgG System, which received an Emergency Use Authorization from the Food and Drug Administration on April 14, 2020. The DPP® COVID-19 IgM/IgG System is authorized for use on fingerstick whole blood, venous whole blood, serum, or plasma (lithium heparin or EDTA) specimens from individ uals suspected of coronavirus disease 2019 (COVID-19) by their healthcare provider. (PDF)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - Category: International Medicine & Public Health Source Type: news